Clinical Trials
- A Phase 3, Randomized, Multicenter, Double-Blind, Placebo-Controlled Study of Acoramidis for Transthyretin Amyloidosis Prevention in the Young (ACT-EARLY Trial)Principal Investigator: Cesia Gallegos KattanNot accepting volunteers
- Not accepting volunteers
- Diseases of the Musculoskeletal System, Diseases of the Nervous SystemExploring the Utility of [18F]3F4AP for Demyelination ImagingNot accepting volunteers